Notícias UCB (PK) - UCBJY | Ações OTCMarkets | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
UCB (PK) (UCBJY)
UCB (PK) (UCBJY) Notícias

UCB (PK) (UCBJY)

98,535

0,477

(0,49%)

Fechado 17 Janeiro 6:00PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Schedule 13g
(sc 13g/a)

Schedule 13g
(sc 13g/a)

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S.

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015

Small Company Offering and Sale of Securities Without Registration (d)

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annua...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of...

UCB, Georgia Institute of Technology Partner to Harness the Power of Predictive Analytics in Epilepsy Care

UCB reinforces its leadership in epilepsy at the 2014 Annual Meeting of the American Epilepsy Society (AES)

UCB shows strong scientific presence at leading rheumatology meeting

Advent International and Avista Capital Partners to Acquire Kremers Urban Pharmaceuticals from UCB

Securities Registration (ads, Immediate) (f-6ef)

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições